Opioid and Drug Abuse Commission

The Opioid and Drug Abuse Commission was a commission that advised the Trump administration on combating the ongoing opioid epidemic claiming more than 30,000 American fatalities annually in the United States.[2] The commission was chaired by New Jersey Governor Chris Christie.[3] The commission disbanded in December 2017.

Opioid and Drug Abuse Commission
Agency overview
FormedMarch 29, 2017; 7 years ago (2017-03-29)
DissolvedDecember 2017
JurisdictionU.S. Government
Agency executive
Parent agencyOffice of National Drug Control Policy
Key document
  • Presidential Executive Order Establishing the President’s Commission on Combating Drug Addiction and the Opioid Crisis
WebsiteExecutive Order 13784 (Archived)
Fentanyl. 2 mg (white powder to the right) is a lethal dose in most people.[1] US penny is 19 mm (0.75 in) wide.

Commission members

edit

Mission

edit

According to a draft of its executive order of creation, the panel was charged with responsibilities to:[5]

The commission's interim recommendations were slated to be due within 90 days of its inauguration and a final report, in October 2017. The final report is: The President's Commission on Combatting Drug Addiction and the Opiod Crisis - final report

See also

edit

References

edit
  1. ^ Fentanyl. Image 4 of 17. US DEA (Drug Enforcement Administration). See archive with caption: "photo illustration of 2 milligrams of fentanyl, a lethal dose in most people".
  2. ^ The Editorial Board (February 3, 2018). "Opinion - How Trump Can Keep His Vows on Opioids and Infrastructure". The New York Times. Retrieved January 13, 2019.
  3. ^ Williams, Weston (March 29, 2017). "To address opioid crisis, Trump to give Chris Christie the helm". Christian Science Monitor. Retrieved July 4, 2017.
  4. ^ THE PRESIDENT’S COMMISSION ON COMBATING DRUG ADDICTION AND THE OPIOID CRISIS
  5. ^ Says, Joe Dupont (March 28, 2017). "Executive order lays out blueprint for Trump opioid commission". STAT. Retrieved July 4, 2017.